TransEnterix Inc. | Mutual Funds
Mutual Funds that own TransEnterix Inc.
5,115,756
2.45%
0
1.33%
09/06/2018
JPMorgan Funds - Global Healthcare Fund
4,230,205
2.02%
0
0.83%
05/31/2018
Vanguard Total Stock Market Index Fund
3,847,632
1.84%
0
0%
07/31/2018
iShares Russell 2000 ETF
3,264,394
1.56%
-1,743
0.04%
09/06/2018
JPMorgan Small Cap Growth Fund
1,837,011
0.88%
147,164
0.42%
07/31/2018
Vanguard Extended Market Index Fund
1,535,963
0.74%
44,763
0.01%
07/31/2018
iShares Russell 2000 Growth ETF
1,493,408
0.72%
0
0.08%
09/06/2018
1,155,818
0.55%
1,155,818
1.17%
06/29/2018
SPDR S&P Health Care Equipment ETF
1,107,679
0.53%
0
0.87%
09/06/2018
Stichting Pensioenfonds ABP (Global Equity Portfolio)
723,441
0.35%
723,441
0%
03/31/2018
| Address |
635 Davis Drive
Morrisville North Carolina 27560
United States
|
|
Employees
|
- |
| Website |
http://www.transenterix.com |
| Updated |
07/08/2019 |
| TransEnterix, Inc. operates as a development stage medical device company. It focuses on research, development and sale of medical device robotics to improve minimally invasive surgery. It offers the Senhance Surgical Robotic System, which offers robotic surgery for laparoscopic abdominal and pelvic surgery, as well as limited thoracic operations excluding cardiac and vascular surgery, and the SurgiBot System which refers to the a single-port, robotically enhanced laparoscopic surgical platform. |
